Ardelyx reported $202.83M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Abbott USD 29.64B 19.74B Mar/2026
Amgen USD 51.89B 1.88B Mar/2026
Ardelyx USD 202.83M 696K Dec/2025
aTyr Pharma USD 12.51M 12.11M Dec/2025
Curis USD 29.43M 10.69M Jun/2024
Sanofi EUR 15.72B 150.06M Dec/2025
TG Therapeutics USD 745.14M 499.5M Mar/2026
United Therapeutics USD 100M 100M Jun/2024
Xoma USD 94.38M 7.82M Sep/2025